AUTL Autolus Therapeutics plc

European equities traded in the US as American depositary receipts opened the week tracking slightly

European equities traded in the US as American depositary receipts Tuesday were tracking lower Tuesd

European equities traded in the US as American depositary receipts were rising sharply late Thursday

European equities traded in the US as American depositary receipts edged higher late Wednesday morni

On August 11, Autolus Therapeutics (NASDAQ:AUTL) reported second-quarter results that finally showed the kind of growth investors had been waiting years to see. Net product revenue hit $45.7 million, up 119% from $20.9 million a year earlier and up from $26.2 million just one quarter prior. Management used the momentum to raise full-year 2026 guidance […]

European equities traded in the US as American depositary receipts were trending higher late Friday

European equities traded in the US as American depositary receipts were trending lower late Wednesda

European equities traded in the US as American depositary receipts were tracking lower late Tuesday

European equities traded in the US as American depositary receipts were marginally higher late Frida

European equities traded in the US as American depositary receipts were trending lower late Thursday

European equities traded in the US as American depositary receipts were tracking lower late Wednesda

European equities traded in the US as American depositary receipts started the week slightly lower l

European equities traded in the US as American depositary receipts were trending higher late Friday

European equities traded in the US as American depositary receipts were tracking higher late Thursda

European equities traded in the US as American depositary receipts were tracking higher late Wednesd

European equities traded in the US as American depositary receipts started the week tracking modestl

European equities traded in the US as American depositary receipts were tracking lower late Friday m

European equities traded in the US as American depositary receipts were higher late Thursday morning

European equities traded in the US as American depositary receipts were tracking higher late Tuesday

Autolus Therapeutics (NASDAQ:AUTL) reported second-quarter 2026 net product revenue of $45.7 million from sales of AUCATZYL, up from $26.2 million in the first quarter and $20.9 million a year earlier, as the company expanded treatment-center access and continued its commercial launch in the United

European equities traded in the US as American depositary receipts were trending higher late Friday

European equities traded in the US as American depositary receipts were heading higher late Thursday